Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003236460 | SCV003934675 | uncertain significance | not specified | 2023-05-26 | criteria provided, single submitter | clinical testing | Variant summary: PKD1 c.4252A>T (p.Thr1418Ser) results in a conservative amino acid change located in the PKD domain (IPR000601) of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 248688 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.4252A>T in individuals affected with Polycystic Kidney Disease 1 and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Fulgent Genetics, |
RCV005021872 | SCV005643275 | likely benign | Polycystic kidney disease, adult type | 2024-01-22 | criteria provided, single submitter | clinical testing |